Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ESLA Estrella Immunopharma

盘前交易 07-29 05:30:01 EDT

0.9200

+0.0100

+1.10%

最高0.9400	最低0.8821	成交量1.53万
今开0.8827	昨收0.9100	日振幅6.36%
总市值3,327万	流通市值927.86万	总股本3,617万
成交额1.43万	换手率0.15%	流通股本1,009万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":0.92,"timestamp":1753732800000,"preClose":0.91,"halted":0,"volume":15314,"delay":0,"floatShares":10085450,"shares":36165589,"eps":-0.285932,"marketStatus":"盘前交易","change":0.01,"latestTime":"07-29 05:30:01 EDT","open":0.8827,"high":0.94,"low":0.8821,"amount":14250.35296,"amplitude":0.063626,"askPrice":1.03,"askSize":200,"bidPrice":0.7996,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.285932,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753795800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.92,"postHourTrading":{"tag":"盘后","latestPrice":0.92,"preClose":0.92,"latestTime":"16:04 EDT","volume":1,"amount":0.92,"timestamp":1753733041430},"volumeRatio":0.5408708209384153},"requestUrl":"/m/hq/s/ESLA","defaultTab":"news","newsList":[{"id":"2551198097","title":"Estrella Immunopharma, Inc.盘中异动 早盘快速跳水5.08%报0.840美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551198097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551198097?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:16","pubTimestamp":1752589009,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时16分，Estrella Immunopharma, Inc.股票出现波动，股价快速下跌5.08%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715221649a6ab689d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715221649a6ab689d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2551184131","title":"Estrella Immunopharma, Inc.盘中异动 早盘大幅下跌7.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551184131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551184131?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:52","pubTimestamp":1752501147,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时52分，Estrella Immunopharma, Inc.股票出现异动，股价快速下挫7.86%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1741.19%、624.89%、471.59%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Biomx Inc.，振幅分别为163.93%、115.31%、87.78%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714215227954230d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714215227954230d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2550506939","title":"Estrella Immunopharma, Inc.盘中异动 股价大跌6.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550506939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550506939?lang=zh_cn&edition=full","pubTime":"2025-07-11 23:58","pubTimestamp":1752249517,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日23时58分，Estrella Immunopharma, Inc.股票出现波动，股价大幅下挫6.75%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711235838a4453430&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711235838a4453430&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2550626440","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨8.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550626440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550626440?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:55","pubTimestamp":1752155701,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时55分，Estrella Immunopharma, Inc.股票出现异动，股价快速上涨8.97%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710215501a442bf79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710215501a442bf79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2549563805","title":"Estrella Immunopharma, Inc.盘中异动 快速上涨7.95%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549563805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549563805?lang=zh_cn&edition=full","pubTime":"2025-07-07 23:19","pubTimestamp":1751901544,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日23时19分，Estrella Immunopharma, Inc.股票出现异动，股价大幅拉升7.95%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为4857.48%、1155.64%、845.14%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.，振幅分别为298.32%、146.56%、84.08%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707231905a43c1c42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707231905a43c1c42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2548817137","title":"Estrella Immunopharma, Inc.股价拉升11.42% 市值跌2.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548817137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548817137?lang=zh_cn&edition=full","pubTime":"2025-07-03 03:56","pubTimestamp":1751486212,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日03时56分，Estrella Immunopharma, Inc.股票出现波动，股价大幅拉升11.42%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703035652a4cbbb7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703035652a4cbbb7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2547101348","title":"Estrella Immunopharma, Inc.盘中异动 早盘快速下跌6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547101348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547101348?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:55","pubTimestamp":1751295338,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日22时55分，Estrella Immunopharma, Inc.股票出现波动，股价快速跳水6.36%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302255389531640f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302255389531640f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2546774745","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大跌6.37%报0.880美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546774745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546774745?lang=zh_cn&edition=full","pubTime":"2025-06-27 23:12","pubTimestamp":1751037121,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日23时12分，Estrella Immunopharma, Inc.股票出现波动，股价大幅下跌6.37%。截至发稿，该股报0.880美元/股，成交量1078股，换手率0.00%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627231201a4c180b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627231201a4c180b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2545231548","title":"Estrella Immunopharma, Inc.盘中异动 大幅上涨5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545231548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545231548?lang=zh_cn&edition=full","pubTime":"2025-06-24 23:42","pubTimestamp":1750779757,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日23时42分，Estrella Immunopharma, Inc.股票出现波动，股价大幅拉升5.87%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624234238a71b8027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624234238a71b8027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2545101034","title":"Estrella Immunopharma, Inc.盘中异动 股价大跌7.07%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545101034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545101034?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:32","pubTimestamp":1750685572,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时32分，Estrella Immunopharma, Inc.股票出现波动，股价快速下挫7.07%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Impact Biomedical, Inc.、Cidara Therapeutics, Inc.、Indaptus Therapeutics, Inc.涨幅较大，Indaptus Therapeutics, Inc.、Impact Biomedical, Inc.、Nucana Plc较为活跃，换手率分别为900.47%、898.95%、200.36%，振幅较大的相关个股有Impact Biomedical, Inc.、Skye Bioscience, Inc.、Indaptus Therapeutics, Inc.，振幅分别为30.38%、19.44%、16.55%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213252a718f170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213252a718f170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2545177590","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨7.75%报1.004美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545177590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545177590?lang=zh_cn&edition=full","pubTime":"2025-06-21 02:50","pubTimestamp":1750445456,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日02时50分，Estrella Immunopharma, Inc.股票出现波动，股价快速拉升7.75%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062102505697884b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062102505697884b18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2544966199","title":"Estrella Immunopharma, Inc.盘中异动 早盘大幅下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544966199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544966199?lang=zh_cn&edition=full","pubTime":"2025-06-17 22:45","pubTimestamp":1750171552,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日22时45分，Estrella Immunopharma, Inc.股票出现异动，股价急速下跌5.20%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617224552a70e8e6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617224552a70e8e6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2543082116","title":"Estrella Immunopharma, Inc.盘中异动 大幅拉升6.25%报1.020美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543082116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543082116?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:47","pubTimestamp":1750081626,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时47分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨6.25%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616214706951ec6e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616214706951ec6e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2542510249","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨5.38%报1.050美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542510249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542510249?lang=zh_cn&edition=full","pubTime":"2025-06-12 21:47","pubTimestamp":1749736070,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日21时47分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨5.38%。截至发稿，该股报1.050美元/股，成交量971股，换手率0.00%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。Estrella 的使命是利用人类免疫系统的进化力量来改变癌症和自身免疫性疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612214750977cb344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612214750977cb344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2542349415","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542349415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542349415?lang=zh_cn&edition=full","pubTime":"2025-06-11 00:39","pubTimestamp":1749573579,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日00时39分，Estrella Immunopharma, Inc.股票出现异动，股价大幅拉升6.21%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大，Nucana Plc、Windtree Therapeutics, Inc.、Evogene Ltd.较为活跃，换手率分别为29468.33%、2779.61%、1329.02%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Klotho Neurosciences, Inc.，振幅分别为261.54%、191.40%、114.83%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506110039399779a151&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506110039399779a151&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2542338602","title":"Estrella Immunopharma, Inc.盘中异动 早盘大幅下挫5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542338602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542338602?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:59","pubTimestamp":1749477584,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时59分，Estrella Immunopharma, Inc.股票出现波动，股价快速下跌5.82%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609215945a700b795&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609215945a700b795&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2541286696","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大跌5.66%报1.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541286696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541286696?lang=zh_cn&edition=full","pubTime":"2025-06-06 22:25","pubTimestamp":1749219903,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日22时25分，Estrella Immunopharma, Inc.股票出现异动，股价快速下跌5.66%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606222503a6fd564c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606222503a6fd564c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2541075915","title":"Estrella Immunopharma, Inc.盘中异动 早盘大幅下挫7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541075915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541075915?lang=zh_cn&edition=full","pubTime":"2025-06-05 21:36","pubTimestamp":1749130597,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日21时36分，Estrella Immunopharma, Inc.股票出现异动，股价快速下跌7.06%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605213637a6fbd7d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605213637a6fbd7d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2540069027","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨5.49%报0.880美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540069027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540069027?lang=zh_cn&edition=full","pubTime":"2025-06-04 21:36","pubTimestamp":1749044187,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日21时36分，Estrella Immunopharma, Inc.股票出现异动，股价急速拉升5.49%。截至发稿，该股报0.880美元/股，成交量7.9216万股，换手率0.22%，振幅2.59%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060421362797718e50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060421362797718e50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2540797410","title":"Estrella Immunopharma, Inc.盘中异动 下午盘快速跳水5.06%报0.959美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540797410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540797410?lang=zh_cn&edition=full","pubTime":"2025-06-03 01:40","pubTimestamp":1748886056,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日01时40分，Estrella Immunopharma, Inc.股票出现波动，股价快速下跌5.06%。截至发稿，该股报0.959美元/股，成交量538股，换手率0.00%，振幅0.99%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.76%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603014057976eadf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603014057976eadf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.estrellabio.com","stockEarnings":[{"period":"1week","weight":0.0952},{"period":"1month","weight":0.0443},{"period":"3month","weight":-0.1598},{"period":"6month","weight":-0.2152},{"period":"1year","weight":-0.5837},{"period":"ytd","weight":-0.2333}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0358},{"period":"3month","weight":0.149},{"period":"6month","weight":0.0584},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Estrella Immunopharma, Inc.于2021年1月6日在特拉华州注册成立。该公司是一家临床前阶段的生物制药公司，开发CD19和CD22靶向ARTEMIS T细胞疗法，有能力应对血癌和实体瘤患者的治疗挑战。该公司的使命是利用人类免疫系统的进化力量，改变癌症患者的生活。为了完成这一使命，该公司的主要候选产品EB103利用Eureka的ARTEMIS技术来靶向CD19，一种在几乎所有B细胞白血病和淋巴瘤表面表达的蛋白质。该公司也在开发EB104，它还利用Eureka的ARTEMIS技术，不仅针对CD19，还针对CD22，一种与CD19一样在大多数B细胞恶性肿瘤表面表达的蛋白质。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":-0.019009},{"month":2,"riseRate":0.5,"avgChangeRate":-0.025426},{"month":3,"riseRate":0.5,"avgChangeRate":0.026432},{"month":4,"riseRate":0.75,"avgChangeRate":0.006035},{"month":5,"riseRate":0.25,"avgChangeRate":-0.040145},{"month":6,"riseRate":0.5,"avgChangeRate":0.017516},{"month":7,"riseRate":0.5,"avgChangeRate":0.094503},{"month":8,"riseRate":0,"avgChangeRate":-0.155794},{"month":9,"riseRate":0.666667,"avgChangeRate":0.067027},{"month":10,"riseRate":0.5,"avgChangeRate":-0.283282},{"month":11,"riseRate":1,"avgChangeRate":0.121807},{"month":12,"riseRate":0.25,"avgChangeRate":-0.071717}],"exchange":"NASDAQ","name":"Estrella Immunopharma","nameEN":"Estrella Immunopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Estrella Immunopharma,ESLA,Estrella Immunopharma股票,Estrella Immunopharma股票老虎,Estrella Immunopharma股票老虎国际,Estrella Immunopharma行情,Estrella Immunopharma股票行情,Estrella Immunopharma股价,Estrella Immunopharma股市,Estrella Immunopharma股票价格,Estrella Immunopharma股票交易,Estrella Immunopharma股票购买,Estrella Immunopharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}